Will short peptides revolutionize chelation therapy?

HIGHLIGHTS

• who: CHIMIA and colleagues from the Michal Shoshan graduated in chemistry and biology at Tel-Aviv University in , and conducted her PhD studies at the Hebrew University of Jerusalem, working on the design of peptidic models for copper metallochaperones, both for mechanistic investigation and as drug candidates for Wilson`s diseaseAfter graduating in, she spent three years at ETH Zurich, where she worked as a Marie Curie postdoctoral fellow in the group of Prof. Helma Wennemers on the development of peptide-coated platinum nanopArticles as antitumor agents. Since, Michal has been a group leader at the Department . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.